{"ticker": {"uuid": "1127813d-6561-4e26-8415-dcc294bd9b9b", "symbol": "IRLAB-A", "name": "IRLAB Therapeutics AB (publ)", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "IRLAB Completes Registration of Rights Issue and Converts Interim Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOZ2ZYRkY2MUFzbHVEYkNMMVNzRnFkNmRUTnp3R0hFNFRMenEwYTVfcWJXSHFUTXBHcm82ZXUxTWcxMUZuc0hVV0dod015RnlvVkVTeUNvQmxhYUpyMThET2tIam9ZTjdOU2l0V3c0Qmh2aERRVjFxWUJyVG1xTDJ6bDlxQlNXMkR3RkZmY3oxeUw1QTdaN0pCUmMzV0hMQ1VLaVE0Y3hkQllXV3R2THUwMmVkWGN4Rm1FenYxc09tLXd5dw?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T14:11:53+00:00", "published_display": "10 Jul 2026 14:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB\u2019s rights issue is registered \u2013 conversion of BTA into shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNLUNYZVdsdTlMaVlfOE93VnQ5WnRfZGZBZ25sRTRGQVpONGszRTVIZllWU0k0bE9qakpGalAwcHUzdDdsTDNEQ1pNeE05V1J5NUxId2ZtMlcyM256bmhhQUhJYW1GZkMxUW1LVUUzSUI1MllaZjBKSy1PYTFoMVpvbU1OeU1Xbi1mcGlsUi1fWi1Xd2hWcFFIbjNtbWpQN0dKTXpMOXdOd0pxYkoyNUZ4OGladWJmWTk3eGx3Ukx2X2pLaGh0TC1ubFVR?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T13:30:00+00:00", "published_display": "10 Jul 2026 13:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Irlab board member James Gamgort buys shares for just under SEK 0.3m", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNGJjNm1SbmltbmtXRkk4SzRrcDhWakVhUzdIcEFnRTVTZ2pFaVZrbDlyUm5Xa3g3bkQ4QUU5d1dCZ3hIN2Y5NHZKUk1rRjhtWC1kVVlLN3FqTHNCd1JqLUh1UHJCVUZCQmRtVU1RZmRyZmhnNlNoVGI3NUVTbTJOYXprbW1kbVFiZHRnOThHVmlCc3VlYWxTUlRpTzZHWExidU9kT1B0X283TjZfa2J3LWsyWWxTY1BFSV9QYXV3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T12:32:25+00:00", "published_display": "08 Jul 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB Raises SEK 76.5 Million in Oversubscribed Rights and Overallotment Issues", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPN1Y0aUR0bmU1Qkh0bmtqaGh4SnBXUWFmWGUwTlhTTHViM0g3eGZMemlWQjNTNWltRnRiYTNOYkJ4a1ZOaWNHTk5zNlBBSGxmcEtjY2pOSU90OTVvUVE4Rkx5WjJzM3daeWNjUGw1ZWJvNUdRZDdxeGVWRnVHMUZHTV8xcWhUNm9jU0tSMjJ6cUNoVmY5Y0FpTHNWZ2YxRU8zX1BBdFNKNUVETXczSjN5akxTUTR1SC1NM0pmYXVlZDg4NG40OU5tb3JvZUNGNkYtUy1GcElkOUZWWU1ISGw2WWJ5ZUozS1hEcDBJQ3M4VzNhQQ?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB presents integrated analysis of mesdopetam data at international conference \u2013 confirms robust efficacy results in the Phase II studies", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAJBVV95cUxNX2R3a3BkZnhnNU01UkM4UFJKbVFoOC1JRkE4RW5QMUk2SHprMF9ERG5VLVdCbXQ0OFpkSFBNVkkxamIwNjhod2VpeVc4aWZaYmVleTJzS2d6VWZwQmE5bTE4dG4tTXJvY0s2b1NJMlJmUkhReUxFN0RfdjZTOW5qSU5DX05rRk1WaVZrenlWdDBkcWZFNm1FYjNrMlotV1FHeG9wanlydG91SjA0TlJHLXZraXo3cWRLR3BFUVkzdS1OX1NITUdXai1ORVZGdzc2djE3ODZBR01qS0o1ZlFKMzhTOFR3a1o4SElKZGpoSThYMU1TMVdNRXJROU56RXBhTnVsUXY3WnAyX3JDZXFPQ1l5Y0NfSTFyYmJ0a1RMWDJSMTJVWDJoNGFhQjE?oc=5", "source_name": "TradingView", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The subscription period in IRLAB\u2019s rights issue commences today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQNlIwa21CT0t5UE14cEVJa2w4LU01R0tBeVUySFYzaVJDbWFwR3d1cTIxX05CU1dwT0hEazUwTHVJNXM3NXM0cWo3dnRYdUFUQ0dTM2xTUGRlRF90NkF3UHRPdGpndUp0bklMbEtYaEZpS0cwSzROTHJITE1LaGFRTGN1cWhqSnI4cUxEcHFpWjhEMFRLNDRsNUhIY3ZBbDRFRjZYc2Q4a1k5eGJ2YUNwRzNzNmNCX0hhTWNqR1hpNWU0bGJrbEtFaQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Report from the Extraordinary General Meeting of IRLAB Therapeutics AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPYUlISWtzRnBBZk9WaXd2WVFJNEpNRmVCclZ3cGFLaWZSQ2RoVFlnOVJ4enI0UG03T1ZiZGlFSWtJZHVaRFdVa2dlNDRVR0J1amxtTktSS3lSSVdOcko1bmx4ci02WkVQSURjYW5FQ0NCMkpyUGdBYkw0Q0QzSlpZektXUHVYZDNJWEhBNFRXMW5pTGVGMHFnZldWN0Mya3ZCR2xYSDdlaXJLQ0xzWF9SWVNkSkJ4Y255VS13LXFfWTdHdEZRWG5rRjYwbGpSVUJzWWc?oc=5", "source_name": "TradingView", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB participates at Aktiedagarna in Stockholm on June 9.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbW82aDZ3MFMzUjRsSEduaE1BWFdJek1qVnNWM1VLUmdCMXVib0I4WUFQbHl0bFg2NEtwRTVoNkhsb2pjSllrdXZPNnRNbEJadkxVU2Y5SFlPTTBnbjExN0p0ay1ybVJ4eVkzWTliWWlxWXo5MVdZNURqbzhiMGN5UUpscUlIWXk2Q1Bqc0hXTlZJaTVSVFFGc2JTYVpHOF9hMUFWU2Q4VlJ0VjRPc01FTmZxc2FDa2gyTlVwN0tkcE0?oc=5", "source_name": "TradingView", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Irlab's shares plummet 60% after Ipsen-partnered Parkinson's drug flunks phase 2 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOVnBXdW1kSzAtTHlScDZsRXBxLTdDa3Zab2J0cnNUNTJlQTNOLTZVOHhjVVptMThBM29DRU80dXdGZERLNjFIck50bWNlUWFzSm12UkhBQThQSXg3X0g1SVFpTV9DTE5ValFTcWM3MmFDN3JNelZoZHJfRVYwNkRLZ0FMMHhMRURmakpabGJwVjBRTGljSF9INjRRZXFBSGtES1A0ZXVhVEd5ZDdGSElPWGFOMEVFUFNaQ3J0T2FB?oc=5", "source_name": "Fierce Biotech", "published_at": "2023-01-18T08:00:00+00:00", "published_display": "18 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "IRLAB Completes Registration of Rights Issue and Converts Interim Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOZ2ZYRkY2MUFzbHVEYkNMMVNzRnFkNmRUTnp3R0hFNFRMenEwYTVfcWJXSHFUTXBHcm82ZXUxTWcxMUZuc0hVV0dod015RnlvVkVTeUNvQmxhYUpyMThET2tIam9ZTjdOU2l0V3c0Qmh2aERRVjFxWUJyVG1xTDJ6bDlxQlNXMkR3RkZmY3oxeUw1QTdaN0pCUmMzV0hMQ1VLaVE0Y3hkQllXV3R2THUwMmVkWGN4Rm1FenYxc09tLXd5dw?oc=5", "source_name": "TipRanks", "published_at": "2026-07-10T14:11:53+00:00", "published_display": "10 Jul 2026 14:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB\u2019s rights issue is registered \u2013 conversion of BTA into shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNLUNYZVdsdTlMaVlfOE93VnQ5WnRfZGZBZ25sRTRGQVpONGszRTVIZllWU0k0bE9qakpGalAwcHUzdDdsTDNEQ1pNeE05V1J5NUxId2ZtMlcyM256bmhhQUhJYW1GZkMxUW1LVUUzSUI1MllaZjBKSy1PYTFoMVpvbU1OeU1Xbi1mcGlsUi1fWi1Xd2hWcFFIbjNtbWpQN0dKTXpMOXdOd0pxYkoyNUZ4OGladWJmWTk3eGx3Ukx2X2pLaGh0TC1ubFVR?oc=5", "source_name": "TradingView", "published_at": "2026-07-10T13:30:00+00:00", "published_display": "10 Jul 2026 13:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Irlab board member James Gamgort buys shares for just under SEK 0.3m", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNNGJjNm1SbmltbmtXRkk4SzRrcDhWakVhUzdIcEFnRTVTZ2pFaVZrbDlyUm5Xa3g3bkQ4QUU5d1dCZ3hIN2Y5NHZKUk1rRjhtWC1kVVlLN3FqTHNCd1JqLUh1UHJCVUZCQmRtVU1RZmRyZmhnNlNoVGI3NUVTbTJOYXprbW1kbVFiZHRnOThHVmlCc3VlYWxTUlRpTzZHWExidU9kT1B0X283TjZfa2J3LWsyWWxTY1BFSV9QYXV3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-08T12:32:25+00:00", "published_display": "08 Jul 2026 12:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB Raises SEK 76.5 Million in Oversubscribed Rights and Overallotment Issues", "summary": "", "url": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPN1Y0aUR0bmU1Qkh0bmtqaGh4SnBXUWFmWGUwTlhTTHViM0g3eGZMemlWQjNTNWltRnRiYTNOYkJ4a1ZOaWNHTk5zNlBBSGxmcEtjY2pOSU90OTVvUVE4Rkx5WjJzM3daeWNjUGw1ZWJvNUdRZDdxeGVWRnVHMUZHTV8xcWhUNm9jU0tSMjJ6cUNoVmY5Y0FpTHNWZ2YxRU8zX1BBdFNKNUVETXczSjN5akxTUTR1SC1NM0pmYXVlZDg4NG40OU5tb3JvZUNGNkYtUy1GcElkOUZWWU1ISGw2WWJ5ZUozS1hEcDBJQ3M4VzNhQQ?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB presents integrated analysis of mesdopetam data at international conference \u2013 confirms robust efficacy results in the Phase II studies", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAJBVV95cUxNX2R3a3BkZnhnNU01UkM4UFJKbVFoOC1JRkE4RW5QMUk2SHprMF9ERG5VLVdCbXQ0OFpkSFBNVkkxamIwNjhod2VpeVc4aWZaYmVleTJzS2d6VWZwQmE5bTE4dG4tTXJvY0s2b1NJMlJmUkhReUxFN0RfdjZTOW5qSU5DX05rRk1WaVZrenlWdDBkcWZFNm1FYjNrMlotV1FHeG9wanlydG91SjA0TlJHLXZraXo3cWRLR3BFUVkzdS1OX1NITUdXai1ORVZGdzc2djE3ODZBR01qS0o1ZlFKMzhTOFR3a1o4SElKZGpoSThYMU1TMVdNRXJROU56RXBhTnVsUXY3WnAyX3JDZXFPQ1l5Y0NfSTFyYmJ0a1RMWDJSMTJVWDJoNGFhQjE?oc=5", "source_name": "TradingView", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The subscription period in IRLAB\u2019s rights issue commences today", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQNlIwa21CT0t5UE14cEVJa2w4LU01R0tBeVUySFYzaVJDbWFwR3d1cTIxX05CU1dwT0hEazUwTHVJNXM3NXM0cWo3dnRYdUFUQ0dTM2xTUGRlRF90NkF3UHRPdGpndUp0bklMbEtYaEZpS0cwSzROTHJITE1LaGFRTGN1cWhqSnI4cUxEcHFpWjhEMFRLNDRsNUhIY3ZBbDRFRjZYc2Q4a1k5eGJ2YUNwRzNzNmNCX0hhTWNqR1hpNWU0bGJrbEtFaQ?oc=5", "source_name": "TradingView", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Report from the Extraordinary General Meeting of IRLAB Therapeutics AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxPYUlISWtzRnBBZk9WaXd2WVFJNEpNRmVCclZ3cGFLaWZSQ2RoVFlnOVJ4enI0UG03T1ZiZGlFSWtJZHVaRFdVa2dlNDRVR0J1amxtTktSS3lSSVdOcko1bmx4ci02WkVQSURjYW5FQ0NCMkpyUGdBYkw0Q0QzSlpZektXUHVYZDNJWEhBNFRXMW5pTGVGMHFnZldWN0Mya3ZCR2xYSDdlaXJLQ0xzWF9SWVNkSkJ4Y255VS13LXFfWTdHdEZRWG5rRjYwbGpSVUJzWWc?oc=5", "source_name": "TradingView", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "IRLAB participates at Aktiedagarna in Stockholm on June 9.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbW82aDZ3MFMzUjRsSEduaE1BWFdJek1qVnNWM1VLUmdCMXVib0I4WUFQbHl0bFg2NEtwRTVoNkhsb2pjSllrdXZPNnRNbEJadkxVU2Y5SFlPTTBnbjExN0p0ay1ybVJ4eVkzWTliWWlxWXo5MVdZNURqbzhiMGN5UUpscUlIWXk2Q1Bqc0hXTlZJaTVSVFFGc2JTYVpHOF9hMUFWU2Q4VlJ0VjRPc01FTmZxc2FDa2gyTlVwN0tkcE0?oc=5", "source_name": "TradingView", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Irlab's shares plummet 60% after Ipsen-partnered Parkinson's drug flunks phase 2 trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOVnBXdW1kSzAtTHlScDZsRXBxLTdDa3Zab2J0cnNUNTJlQTNOLTZVOHhjVVptMThBM29DRU80dXdGZERLNjFIck50bWNlUWFzSm12UkhBQThQSXg3X0g1SVFpTV9DTE5ValFTcWM3MmFDN3JNelZoZHJfRVYwNkRLZ0FMMHhMRURmakpabGJwVjBRTGljSF9INjRRZXFBSGtES1A0ZXVhVEd5ZDdGSElPWGFOMEVFUFNaQ3J0T2FB?oc=5", "source_name": "Fierce Biotech", "published_at": "2023-01-18T08:00:00+00:00", "published_display": "18 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 63, "total_relevant": 9, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 8, "score": 52, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 4.4, "count": 8}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 1.4, "latest_week": "2026-07-10", "one_week_move": 8.4, "four_week_move": 12.6, "twelve_week_move": -9.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.112366, "market_dynamics_buy_signal": false, "relative_strength": -39.510041, "fair_value_gap": -82.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.4641, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+8.4% over one week, +12.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 5}, {"label": "TipRanks", "count": 1}, {"label": "marketscreener.com", "count": 1}, {"label": "The Globe and Mail", "count": 1}, {"label": "Fierce Biotech", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 8}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+8.4% over one week, +12.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "IRLAB Completes Registration of Rights Issue and Converts Interim Shares"}], "updated_at": "2026-07-17T13:09:17.435426+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}